News
Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of ...
Tata Electronics is in discussions with Merck for an exclusive long-term agreement, potentially securing a primary supplier ...
We recently published 10 Stocks Jim Cramer Discussed As He Questioned Official Data. Merck & Co., Inc. (NYSE:MRK) is one of ...
Merck’s second quarter performance aligned with Wall Street’s revenue expectations but drew a negative reaction from the ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Over the past six months, Merck’s stock price fell to $80.05. Shareholders have lost 6.6% of their capital, which is ...
Merck KGaA is in the investment-grade market Tuesday, a day after holding investor calls, to help fund its $3.9 billion ...
This week, Merck filed a notice in accordance with New Jersey's WARN Act, indicating it plans to eliminate 58 positions at ...
Merck's Phase 3 trial shows Keytruda plus Padcev improves survival in muscle-invasive bladder cancer patients ineligible for ...
On July 9, Merck announced that it would acquire Verona Pharma, a U.K.-based biotechnology company specializing in the development of medicines for respiratory diseases. Merck will pay $10 billion in ...
The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...
German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results